Cardiac testing for coronary artery disease in potential kidney transplant recipients

Cochrane Database of Systematic Reviews

Volumn 2011, Issue 12, 2011, Pages

  Wang, Louis W ^a,b   Fahim, Magid A ^c   Hayen, Andrew ^b   Mitchell, Ruth L ^d   Baines, Laura ^e   Lord, Stephen ^e   Craig, Jonathan C ^b,d   Webster, Angela C ^b,d,f  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

^d CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^e NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^f UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOCARDIOGRAPHY; CHRONIC KIDNEY FAILURE; CORONARY ARTERY DISEASE; HEART FUNCTION TEST; HUMAN; KIDNEY TRANSPLANTATION; META ANALYSIS; METHODOLOGY; PANCREAS TRANSPLANTATION; REVIEW; STANDARD;

CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; HEART FUNCTION TESTS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; PANCREAS TRANSPLANTATION; REFERENCE STANDARDS;

EID: 84878530092     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD008691.pub2     Document Type: Review

References (117)

1. Bates JR, Sawada SG, Segar DS, Spaedy AJ, Petrovic O, Fineberg NS, et al. Evaluation using dobutamine stress echocardiography in patients with insulin-dependent diabetes mellitus before kidney and/or pancreas transplantation. American Journal of Cardiology 1996;77(2):175-9. [MEDLINE: 8546087]
2. Bennett WM, Kloster F, Rosch J, Barry J, Porter GA. Natural history of asymptomatic coronary arteriographic lesions in diabetic patients with end-stage renal disease. American Journal of Medicine 1978;65(5):779-84. [MEDLINE: 360837]
3. Boudreau RJ, Strony JT, DuCret RP, Kuni CC, Wang Y, Wilson R, F, et al. Perfusion thallium imaging of type I diabetes patients with end stage renal disease: Comparison of oral and intravenous dipyridamole administration. Radiology 1990;175(1):103-5. [MEDLINE: 2315467]
4. Brennan DC, Vedala G, Miller SB, Anstey ME, Singer GG, Kovacs, A, et al. Pretransplant dobutamine stress echocardiography is useful and cost-effective in renal transplant candidates. Transplantation Proceedings 1997;29(1-2):233-4. [MEDLINE: 9122976]
5. Cai Q, Serrano R, Kalyanasundaram A, Shirani J. A preoperative echocardiographic predictive model for assessment of cardiovascular outcome after renal transplantation. Journal of the American Society of Echocardiography 2010;23(5):560-6. [MEDLINE: 20381999]
6. De Lima JJG, Sabbaga E, Vieira MLC, De Paula FJ, Ianhez LE, Krieger EM, et al. Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing. Hypertension 2003;42(3):263-8. [MEDLINE: 12913060]
7. Ferreira PAM, De Lima VC, Campos FO, Gil MA, Cordovil A, Machado, CV, et al. Feasibility, safety and accuracy of dobutamine/atropine stress echocardiography for the detection of coronary artery disease in renal transplant candidates. Arquivos Brasileiros de Cardiologia 2007;88(1):41-7. [MEDLINE: 17364118]
8. Gang S, Dabhi M, Rajapurkar MM. Ischaemia imaging in type 2 diabetic kidney transplant candidates - is coronary angiography essential?. Nephrology Dialysis Transplantation 2007;22(8):2334-8. [MEDLINE: 17550928]
9. Garcia-Canton C, Culebras C, Hernandez-Briz MJ, Palomar R, Moreno A, Toledo A, et al. Dobutamine stress echocardiography and stress 99M-Technetium methoxyisobutylisonitrile SPECT in the assessment of coronary artery disease in kidney transplant candidates [abstract]. Journal of the American Society of Nephrology 1998;9(September, Program and Abstracts):708.
10. Garg N, Kapoor A, Umesan CV, Sharma RK, Sinha N. Role of pretransplant arteriography in diabetic end-stage renal disease. Asian Cardiovascular and Thoracic Annals 2000;8(2):150-4. [EMBASE: 2000282610]
11. Gowdak LH, De Paula FJ, De Oliveira AL, Arantes RL, Cesar LA, Ramires JA, et al. Non-invasive screening for coronary artery disease in renal transplant candidates with diabetes is influenced by gender. European Society of Cardiology Congress; 2010 Aug 28-Sep 01; Stockholm, Sweden. http://spo.escardio.org/AbstractDetails.aspx?id=91377 (last accessed 04 Oct 2011). 2010.
12. Herzog CA, Marwick TH, Pheley AM, White CW, Rao VK, Dick CD. Dobutamine stress echocardiography for the detection of significant coronary artery disease in renal transplant candidates. American Journal of Kidney Diseases 1999;33(6):1080-90. [MEDLINE: 10352196]
13. Jassal DS, Neilan TG, Picard MH, Wood MJ. Stress echocardiography: Abnormal response of tissue Doppler-derived indices to dobutamine in the absence of obstructive coronary artery disease in patients with chronic renal failure. Echocardiography 2007;24(6):580-6. [MEDLINE: 17584197]
14. Krawczynska EG, DePuey EG, Whelchel JD. Tl-201 cardiac SPECT to evaluate pre-renal transplant patients [abstract]. Journal of Nuclear Medicine 1988;29(5 Suppl):950.
15. Marwick T, Hobbs R, Vanderlaan RL, Steinmuller D, Braun W. Use of digital subtraction fluorography in screening for coronary artery disease in patients with chronic renal failure. American Journal of Kidney Diseases 1989;14(2):105-9. [MEDLINE: 2667345]
16. Marwick TH, Steinmuller DR, Underwood DA, Hobbs RE, Go RT, Swift C, et al. Ineffectiveness of dipyridamole SPECT thallium imaging as a screening technique for coronary artery disease in patients with end-stage renal failure. Transplantation 1990;49(1):100-3. [MEDLINE: 2300998]
17. Modi N, Kapoor A, Kumar S, Tewari S, Garg N, Sinha N. Utility of carotid intimal medial thickness as a screening tool for evaluation of coronary artery disease in pre-transplant end stage renal disease. Journal of Postgraduate Medicine 2006;52(4):266-70. [MEDLINE: 17102544]
18. Reis G, Marcovitz PA, Leichtman AB, Merion RM, Fay WP, Werns SW, et al. Usefulness of dobutamine stress echocardiography in detecting coronary artery disease in end-stage renal disease. American Journal of Cardiology 1995;75(10):707-10. [MEDLINE: 7900665]
19. Rosario MA, de Lima JJ, Parga JR, Avila LF, Gowdak LH, Lemos PA, et al. Coronary calcium score as predictor of stenosis and events in pretransplant renal chronic failure. Arquivos Brasileiros de Cardiologia 2010;94(2):239-43. [MEDLINE: 20428622]
20. Sharma R, Pellerin D, Gaze DC, Gregson H, Streather CP, Collinson PO, et al. Dobutamine stress echocardiography and the resting but not exercise electrocardiograph predict severe coronary artery disease in renal transplant candidates. Nephrology Dialysis Transplantation 2005;20(10):2207-14. [MEDLINE: 16030034]
21. Sharma R, Pellerin D, Gaze DC, Shah JS, Streather CP, Collinson PO, et al. Dobutamine stress echocardiography and cardiac troponin T for the detection of significant coronary artery disease and predicting outcome in renal transplant candidates. European Journal of Echocardiography 2005;6(5):327-35. [MEDLINE: 15985387]
22. Sharma R, Mehta RL, Brecker SJD, Gaze DC, Gregson H, Streather CP, et al. The diagnostic and prognostic value of tissue Doppler imaging during dobutamine stress echocardiography in end-stage renal disease. Coronary Artery Disease 2009;20(3):230-7. [MEDLINE: 19387250]
23. Sharples EJ, Pereira D, Summers S, Cunningham J, Rubens M, Goldsmith D, et al. Coronary artery calcification measured with electron-beam computerized tomography correlates poorly with coronary artery angiography in dialysis patients. American Journal of Kidney Diseases 2004;43(2):313-9. [MEDLINE: 14750097]
24. Vandenberg BF, Rossen JD, Grover-Mckay M, Shammas NW, Burns TL, Rezai K. Evaluation of diabetic patients for renal and pancreas transplantation: Noninvasive screening for coronary artery disease using radionuclide methods. Transplantation 1996;62(9):1230-5. [MEDLINE: 8932262]
25. West JC, Napoliello DA, Costello JM, Nassef LA, Butcher RJ, Hartle JE, et al. Preoperative dobutamine stress echocardiography versus cardiac arteriography for risk assessment prior to renal transplantation. Transplant International 2000;13(Suppl 1):S27-30. [MEDLINE: 11111956]
26. Worthley MI, Unger SA, Mathew TH, Russ GR, Horowitz JD. Usefulness of tachycardic-stress perfusion imaging to predict coronary artery disease in high-risk patients with chronic renal failure. American Journal of Cardiology 2003;92(11):1318-20. [MEDLINE: 14636911]
27. Ali M, Giblin L, Farhad K, O'Kelly P, Hickey D, Little D, et al. Pretransplant cardiac investigations in the Irish renal transplant population--the effectiveness of our current screening techniques in predicting cardiac events. Renal Failure 2004;26(4):375-80. [MEDLINE: 15462104]
28. Arantes RL, Gowdak LH, Paula FJ, Ianhez LE, Ramires JAF, Krieger EM, et al. Myocardial scintigraphy and clinical stratification as predictors of events in renal transplant candidates. Journal of Nephrology 2010;23(3):314-20. [MEDLINE: 20349410]
29. Braun WE, Phillips DF, Vidt DG, Novick AC, Nakamoto S, Popowniak KL, et al. Coronary artery disease in 100 diabetics with end-stage renal failure. Transplantation Proceedings 1984;16(3):603-7. [MEDLINE: 6375027]
30. Brown KA, Rimmer J, Haisch C. Noninvasive cardiac risk stratification of diabetic and nondiabetic uremic renal allograft candidates using dipyridamole-thallium-201 imaging and radionuclide ventriculography. American Journal of Cardiology 1989;64(16):1017-21. [MEDLINE: 2816731]
31. Caglar M, Mahmoudian B, Aytemir K, Kahraman S, Arici M, Kabakci G, et al. Value of 99mTc-methoxyisobutylisonitrile (99mTc-MIBI) gated SPECT for the detection of silent myocardial ischemia in hemodialysis patients: clinical variables associated with abnormal test results. Nuclear Medicine Communications 2006;27(1):61-9. [MEDLINE: 16340725]
32. Camp AD, Garvin PJ, Hoff J, Marsh J, Byers SL, Chaitman BR. Prognostic value of intravenous dipyridamole thallium imaging in patients with diabetes mellitus considered for renal transplantation. American Journal of Cardiology 1990;65(22):1459-63. [MEDLINE: 2353652]
33. Cortigiani L, Desideri A, Gigli G, Vallebona A, Terlizzi R, Giusti R, et al. Clinical, resting echo and dipyridamole stress echocardiography findings for the screening of renal transplant candidates. International Journal of Cardiology 2005;103(2):168-74. [MEDLINE: 16080976]
34. Cottier C, Pfisterer M, Muller-Brand J, Thiel G, Burkart F. Cardiac evaluation of candidates for kidney transplantation: value of exercise radionuclide angiocardiography. European Heart Journal 1990;11(9):832-8. [MEDLINE: 2226509]
35. Cross DS, Alagarsamy SH, Adams M, Esquivel-Avila JG, Carson R, Ahmad M. Dobutamine stress echocardiography for risk stratification in patients for renal transplantation [abstract no: 3967]. Circulation 1996;94.
36. Dahan M, Legallicier B, Himbert D, Faraggi M, Aubry N, Siohan P, et al. [Diagnostic value of myocardial thallium stress scintigraphy in the detection of coronary artery disease in patients undergoing chronic hemodialysis] [Valeur diagnostique de la scintigraphie myocardique au thallium sous stimulation dans la detection de la maladie coronarienne chez l'hemodialyse chronique]. Archives des Maladies du Coeur et des Vaisseaux 1995;88(8):1121-3. [MEDLINE: 8572857]
37. Dahan M, Viron BM, Faraggi M, Himbert DL, Legallicier BJ, Kolta AM, et al. Diagnostic accuracy and prognostic value of combined dipyridamole- exercise thallium imaging in hemodialysis patients. Kidney International 1998;54(1):255-62. [MEDLINE: 9648086]
38. Dahan M, Viron BM, Poiseau E, Kolta AM, Aubry N, Paillole C, et al. Combined dipyridamole-exercise stress echocardiography for detection of myocardial ischemia in hemodialysis patients: An alternative to stress nuclear imaging. American Journal of Kidney Diseases 2002;40(4):737-44. [MEDLINE: 12324908]
39. De Vriese AS, De Bacquer DA, Verbeke FH, De Winter O, Franken PR, De Sutter JH, et al. Comparison of the prognostic value of dipyridamole and dobutamine myocardial perfusion scintigraphy in hemodialysis patients. Kidney International 2009;76(4):428-36. [MEDLINE: 19494798]
40. Derfler K, Kletter K, Balcke P, Heinz G, Dudczak R. Predictive value of thallium-201-dipyridamole myocardial stress scintigraphy in chronic hemodialysis patients and transplant recipients. Clinical Nephrology 1991;36(4):192-202. [MEDLINE: 1959245]
41. Dussol B, Bonnet J-L, Sampol J, Savin B, De La Forte C, Mundler O, et al. Prognostic value of inducible myocardial ischemia in predicting cardiovascular events after renal transplantation. Kidney International 2004;66(4):1633-9. [MEDLINE: 15458460]
42. Eschertzhuber S, Hohlrieder M, Boesmueller C, Pomaroli A, Steurer W, Junker T, et al. Incidence of coronary heart disease and cardiac events in patients undergoing kidney and pancreatic transplantation. Transplantation Proceedings 2005;37(2):1297-300. [MEDLINE: 15848702]
43. Feola M, Biggi A, Ribichini F, Rovere A, Vado A, Camuzzini G, et al. Predicting cardiac events with TL201 dipyridamole myocardial scintigraphy in renal transplant recipients. Journal of Nephrology 2002;15(1):48-53. [MEDLINE: 11936426]
44. Fossati N, Meacci L, Amorese G, Bellissima G, Pieri M, Nardi S, et al. Cardiac evaluation for simultaneous pancreas-kidney transplantation and incidence of cardiac perioperative complications: Preliminary study. Transplantation Proceedings 2004;36(3):582-5. [MEDLINE: 15110601]
45. Fujimoto N, Iseki K, Tokuyama K, Tamashiro M, Takishita S. Significance of coronary artery calcification score (CACS) for the detection of coronary artery disease (CAD) in chronic dialysis patients. Clinica Chimica Acta 2006;367(1-2):98-102. [MEDLINE: 16413522]
46. Fukui M, Mori Y, Takehana K, Masaki H, Motohiro M, Sakamoto N, et al. Assessment of coronary artery disease in hemodialysis patients with delayed systolic blood pressure response after exercise testing. Blood Purification 2005;23(6):466-72. [MEDLINE: 16282683]
47. Fuster D, Magrina J, Ricart MJ, Pascual J, Laterza C, Setoain FJ, et al. Noninvasive assessment of cardiac risk in type I diabetic patients being evaluated for combined pancreas-kidney transplantation using dipyridamole-MIBI perfusion tomographic scintigraphy. Transplant International 2000;13(5):327-32. [MEDLINE: 11052267]
48. Holley JL, Fenton RA, Arthur RS. Thallium stress testing does not predict cardiovascular risk in diabetic patients with end-stage renal disease undergoing cadaveric renal transplantation. American Journal of Medicine 1991;90(5):563-70. [MEDLINE: 2029013]
49. Iqbal A, Gibbons RJ, McGoon MD, Sterioff S, Frohnert PP, Velosa JA. Noninvasive assessment of cardiac risk in insulin-dependent diabetic patients being evaluated for pancreatic transplantation using thallium-201 myocardial perfusion scintigraphy. Clinical Transplantation 1991;5(1):13-9. [MEDLINE: 10147633]
50. Jeloka TK, Ross H, Smith R, Huang M, Fenton S, Cattran D, et al. Renal transplant outcome in high-cardiovascular risk recipients. Clinical Transplantation 2007;21(5):609-14. [MEDLINE: 17845634]
51. Krotin M, Vukovic D, Stojanovic O, Milovanovic B, Celeketic D, Blagojevic R. Prognostic value of dobutamine stress echocardiography in patients with terminal renal insufficiency undergoing hemodialysis - a 5-year follow up. Medicinski Pregled 2007;60(7-8):333-7. [MEDLINE: 17990798]
52. Langford EJ, De Belder AJ, Cairns H, Hendry BM, Wainwright RJ. Non-invasive cardiac investigations in patients awaiting renal transplantation. Journal of the Royal Society of Medicine 1997;90(3):136-7. [MEDLINE: 9135610]
53. Le A, Wilson R, Douek K, Pulliam L, Tolzman D, Norman D, et al. Prospective risk stratification in renal transplant candidates for cardiac death. American Journal of Kidney Diseases 1994;24(1):65-71. [MEDLINE: 8023826]
54. Leonardi G, Tamagnone M, Ferro M, Tognarelli G, Messina M, Giraudi R, et al. Assessment of cardiovascular risk in waiting-listed renal transplant patients: a single center experience in 558 cases. Clinical Transplantation 2009;23(5):653-9. [MEDLINE: 19563485]
55. Lewis MS, Wilson RA, Walker KW, Wilson DJ, Norman DJ, Barry JM, et al. Validation of an algorithm for predicting cardiac events in renal transplant candidates. American Journal of Cardiology 2002;89(7):847-50. [MEDLINE: 11909572]
56. Lin K, Stewart D, Cooper S, Davis CL. Pre-transplant cardiac testing for kidney-pancreas transplant candidates and association with cardiac outcomes. Clinical Transplantation 2001;15(4):269-75. [MEDLINE: 11683822]
57. Ma IW, Valantine HA, Shibata A, Waskerwitz J, Dafoe DC, Alfrey EJ, et al. Validation of a screening protocol for identifying low-risk candidates with type 1 diabetes mellitus for kidney with or without pancreas transplantation. Clinical Transplantation 2006;20(2):139-46. [MEDLINE: 16640517]
58. Manske CL, Wilson RF, Wang Y, Thomas W. Atherosclerotic vascular complications in diabetic transplant candidates. American Journal of Kidney Diseases 1997;29(4):601-7. [MEDLINE: 9100051]
59. Mao J, Karthikeyan V, Poopat C, Song T, Pantelic M, Chattahi J, et al. Coronary computed tomography angiography in dialysis patients undergoing pre-renal transplantation cardiac risk stratification. Cardiology Journal 2010;17(4):349-61. [MEDLINE: 20690090]
60. Mistry BM, Bastani B, Solomon H, Hoff J, Aridge DL, Lindsey LM, et al. Prognostic value of dipyridamole thallium-201 screening to minimize perioperative cardiac complications in diabetics undergoing kidney or kidney-pancreas transplantation. Clinical Transplantation 1998;12(2):130-5. [MEDLINE: 9575401]
61. Morrow CE, Schwartz JS, Sutherland DE, Simmons RL, Ferguson RM, Kjellstrand CM, et al. Predictive value of thallium stress testing for coronary and cardiovascular events in uremic diabetic patients before renal transplantation. American Journal of Surgery 1983;146(3):331-5. [MEDLINE: 6351648]
62. Nguyen PT, Coche E, Goffin E, Beguin C, Vlassenbroek A, Devuyst O, et al. Prevalence and determinants of coronary and aortic calcifications assessed by chest CT in renal transplant recipients. American Journal of Nephrology 2007;27(4):329-35. [MEDLINE: 17505133]
63. Nishimura M, Hashimoto T, Kobayashi H, Fukuda T, Okino K, Yamamoto N, et al. Myocardial scintigraphy using a fatty acid analogue detects coronary artery disease in hemodialysis patients. Kidney International 2004;66(2):811-9. [MEDLINE: 15253738]
64. Ohtake T, Kobayashi S, Moriya H, Negishi K, Okamoto K, Maesato K, et al. High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination. Journal of the American Society of Nephrology 2005;16(4):1141-8. [MEDLINE: 15743997]
65. Oliveira DC, Filho GG, Nakamoto A, Souza FL, De Sa JR, Pestana JO, et al. Prevalence of coronary artery disease in type I diabetic candidates for double transplantation (kidney and pancreas). Arquivos Brasileiros de Cardiologia 2005;84(2):108-110. [MEDLINE: 15761631]
66. Patel AD, Abo-Auda WS, Davis JM, Zoghbi GJ, Deierhoi MH, Heo J, et al. Prognostic value of myocardial perfusion imaging in predicting outcome after renal transplantation. American Journal of Cardiology 2003;92(2):146-51. [MEDLINE: 12860215]
67. Patel RK, Mark PB, Johnston N, McGeoch R, Lindsay M, Kingsmore DB, et al. Prognostic value of cardiovascular screening in potential renal transplant recipients: a single-center prospective observational study. American Journal of Transplantation 2008;8(8):1673-83. [MEDLINE: 18510627]
68. Philipson JD, Carpenter BJ, Itzkoff J, Hakala TR, Rosenthal JT, Taylor RJ, et al. Evaluation of cardiovascular risk for renal transplantation in diabetic patients. American Journal of Medicine 1986;81(4):630-4. [MEDLINE: 3532789]
69. Porter GA, Norton TL, Lindsley J, Stevens JS, Phillips DS, Bennett WM. Relationship between elevated serum troponin values in end-stage renal disease patients and abnormal isotopic cardiac scans following stress. Renal Failure 2003;25(1):55-65. [MEDLINE: 12617333]
70. Rakhit DJ, Armstrong KA, Beller E, Isbel NM, Marwick TH. Risk stratification of patients with chronic kidney disease: Results of screening strategies incorporating clinical risk scoring and dobutamine stress echocardiography. American Heart Journal 2006;152(2):363-70. [MEDLINE: 16875924]
71. Robinson J, Tan AU, Wilensky RL, Matthai W, Munoz M, Rosas SE. Electron-beam computerized tomography correlates with coronary angiogram in chronic kidney disease patients. American Journal of Nephrology 2007;27(3):247-52. [MEDLINE: 17389785]
72. Russell JD, Stanton EB, Lambert K, et al. Risk stratification for cardiovascular disease in renal transplant candidates: The role of dipyridamole thallium scintigraphy [abstract]. Journal of the American Society of Nephrology. 1993; Vol. 4, issue 3:960.
73. Schmidt A, Stefenelli T, Schuster E, Mayer G. Informational contribution of noninvasive screening tests for coronary artery disease in patients on chronic renal replacement therapy. American Journal of Kidney Diseases 2001;37(1):56-63. [MEDLINE: 11136168]
74. Sharma R, Chemla E, Tome M, Mehta RL, Gregson H, Brecker SJ, et al. Echocardiography-based score to predict outcome after renal transplantation. Heart 2007;93(4):464-9. [MEDLINE: 16980518]
75. Tita C, Karthikeyan V, Stroe A, Jacobsen G, Ananthasubramaniam K. Stress echocardiography for risk stratification in patients with end-stage renal disease undergoing renal transplantation. Journal of the American Society of Echocardiography 2008;21(4):321-6. [MEDLINE: 17681725]
76. Trochu JN, Cantarovich D, Renaudeau J, Patra O, du Roscoat P, Helias J. Assessment of coronary artery disease by thallium scan in type-1 diabetic uremic patients awaiting combined pancreas and renal transplantation. Angiology 1991;42(4):302-7. [MEDLINE: 2014921]
77. Venkataraman R, Hage FG, Dorfman T, Heo J, Aqel RA, de Mattos AM, et al. Role of myocardial perfusion imaging in patients with end-stage renal disease undergoing coronary angiography. American Journal of Cardiology 2008;102(11):1451-6. [MEDLINE: 19026294]
78. Weinrauch L, D'Elia JA, Healy RW, Gleason RE, Christleib AR, Leland OS. Asymptomatic coronary artery disease: angiographic assessment of diabetics evaluated for renal transplantation. Circulation 1978;58(6):1184-90. [MEDLINE: 361277]
79. Weinrauch LA, D'Elia JA, Monaco AP, Gleason RE, Welty F, Nishan PC, et al. Preoperative evaluation for diabetic renal transplantation: Impact of clinical, laboratory, and echocardiographic parameters on patient and allograft survival. American Journal of Medicine 1992;93(1):19-28. [MEDLINE: 1626568]
80. Witczak BJ, Hartmann A, Jenssen T, Foss A, Endresen K. Routine coronary angiography in diabetic nephropathy patients before transplantation. American Journal of Transplantation 2006;6(10):2403-8. [MEDLINE: 16952302]
81. Wong CF, Little MA, Vinjamuri S, Hammad A, Harper JM. Technetium myocardial perfusion scanning in prerenal transplant evaluation in the United Kingdom. Transplantation Proceedings 2008;40(5):1324-28. [MEDLINE: 18589097]
82. Akesson L, Svensson A, Edenbrandt L. Operator dependent variability in quantitative analysis of myocardial perfusion images. Clinical Physiology and Functional Imaging 2004;24(6):374-9. [MEDLINE: 15522047]
83. Alderman EL, Corley SD, Fisher LD, Chaitman BR, Faxon DP, Foster ED, et al. Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). CASS Participating Investigators and Staff. Journal of the American College of Cardiology 1993;22(4):1141-54. [MEDLINE: 8409054]
84. Briggs JD. Causes of death after renal transplantation. Nephrology Dialysis Transplantation 2001;16(8):1545-9. [MEDLINE: 11477152]
85. Burkhoff D, Jones JW, Becker LC. Variability of myocardial perfusion defects assessed by thallium-201 scintigraphy in patients with coronary artery disease not amenable to angioplasty or bypass surgery. Journal of the American College of Cardiology 2001;38(4):1033-9. [MEDLINE: 1583878]
86. Caliskan Y, Oflaz H, Demirturk M, Yazici H, Turkmen A, Cimen A, et al. Coronary flow reserve dysfunction in hemodialysis and kidney transplant patients. Clinical Transplantation 2008;22(6):785-93. [MEDLINE: 19040561]
87. de Lima JJG, Gowdak LHW, de Paula FJ, Arantes RL, de Oliveira ALV, Ramires JAF, et al. Treatment of coronary artery disease in hemodialysis patients evaluated for transplant-A registry study. Transplantation 2010;89(7):845-50. [MEDLINE: 20019646]
88. de Vet HCW, Eisinga A, Riphagen II, Aertgeerts B, Pewsner D. Chapter 7: Searching for Studies. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. Version 0.4 [updated September 2008]. The Cochrane Collaboration, 2008.
89. Doust JA, Pietrzak E, Sanders S, Glasziou PP. Identifying studies for systematic reviews of diagnostic tests was difficult due to the poor sensitivity and precision of methodologic filters and the lack of information in the abstract. Journal of Clinical Epidemiology 2005;58(5):444-9. [MEDLINE: 15845330]
90. Dudley C, Harden P. Assessment for renal transplantation, 4th edition. UK Renal Association. http://www.renal.org/guidelines (accessed 17 January 2010) 2008.
91. Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 2004;110(9):1168-1176. [DOI: 10.1161/01.CIR.0000138790.14877.7D]
92. Fleischmann KE, Hunink MGM, Kuntz KM, Douglas PS. Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance. JAMA 1998;280(10):913-20. [MEDLINE: 9739977]
93. Gunnarsson R, Lofmark R, Nondlander R, Nyquist O, Groth CG. Acute myocardial infarction in renal transplant recipients: incidence and prognosis. European Heart Journal 1984;5(3):218-21. [MEDLINE: 6373265]
94. Hofmann RM. Pretransplant cardiac evaluation: does it really prevent cardiovascular complications?. American Journal of Transplantation 2008;8(8):1575-7. [MEDLINE: 18694471]
95. Houghton JL, Frank MJ, Carr AA, von Dohlen TW, Prisant LM. Relations among impaired coronary flow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease. Journal of the American College of Cardiology 1990;15(1):43-51. [MEDLINE: 2136877]
96. Kasiske BL, Cangro CB, Hariharan S, Hricik DE, Kerman RH, Roth D, et al. The evaluation of renal transplantation candidates: clinical practice guidelines. American Journal of Transplantation 2001;1(Suppl 2):3-95. [MEDLINE: 12108435]
97. Knoll G, Cockfield S, Blydt-Hansen T, Baran D, Kiberd B, Landsberg D, et al. Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation. CMAJ Canadian Medical Association Journal 2005;173(10):S1-25. [MEDLINE: 16275956]
98. Leeflang MMG, Scholten RJPM, Rutjes AWS, Reitsma JB, Bossuyt PMM. Use of methodological search filters to identify diagnostic accuracy studies can lead to the omission of relevant studies. Journal of Clinical Epidemiology 2006;59(3):234-40. [MEDLINE: 16488353]
99. Leeflang MMG, Bossuyt PMM, Irwig L. Diagnostic test accuracy may vary with prevalence: implications for evidence-based diagnosis. Journal of Clinical Epidemiology 2009;62(1):5-12. [MEDLINE: 18778913]
100. Lentine KL, Brennan DC, Schnitzler MA. Incidence and predictors of myocardial infarction after kidney transplantation. Journal of the American Society of Nephrology 2005;16(2):496-506. [MEDLINE: 15615820]
101. Macaskill P. Empirical bayes estimates generated in a hierarchical summary ROC analysis agreed closely with those of a full Bayesian analysis. Journal of Clinical Epidemiology 2004;57:925-32. [MEDLINE: 15504635]
102. Manoharan G, Ntalianis A, Muller O, Hamilos M, Sarno G, Melikian N, et al. Severity of coronary arterial stenoses responsible for acute coronary syndromes. American Journal of Cardiology 2009;103(9):1183-8. [MEDLINE: 19406256]
103. McFalls EO, Ward HB, Moritz TE, Goldman S, Krupski WC, Littooy F, et al. Coronary-artery revascularization before elective major vascular surgery. New England Journal of Medicine 2004;351:2795-804. [MEDLINE: 15625331]
104. National Clinical Guideline Centre for Acute and Chronic Conditions. National Clinical Guideline 95. Chest pain of recent onset: Assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin. NHS National Institute for Health and Clinical Excellence. http://www.nice.org.uk/guidance/CG95. (accessed June 9 2010) March 2010.
105. Niizuma S, Takiuchi S, Okada S, Horio T, Kamide K, Nakata H, et al. Decreased coronary flow reserve in haemodialysis patients. Nephrology Dialysis Transplantation 2008;23(7):2324-8. [MEDLINE: 18234846]
106. Poldermans D, Schouten O, Vidakovic R, Bax JJ. Thomson IR. Hoeks SE, et al. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V pilot study. Journal of the American College of Cardiology 2007;49(17):1763-9. [MEDLINE: 17466225]
107. Rechavia E, Araujo LI, De Silva R, Kushwaha SS, Lammertsma AA, Jones T, et al. Dipyridamole vasodilator response after human orthotopic heart transplantation: quantification by oxygen-15-labeled water and positron emission tomography. Journal of the American College of Cardiology 1992;19(1):100-6. [MEDLINE: 1729318]
108. Reitsma JB, Rutjes AWS, Whiting P, Vlassov VV, Leeflang MMG, Deeks JJ. Chapter 9: Assessing methodological quality. In: Deeks JJ, Bossuyt PM, Gatsonis C (editors), Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0.0. The Cochrane Collaboration, 2009. Available from: http://srdta.cochrane.org.
109. Ritchie G, Glanville J, Lefebvre C. Do published search filters to identify diagnostic test accuracy studies perform adequately?. Health Information and Libraries Journal 2007;24(3):188-92. [MEDLINE: 17714173]
110. Rutter CM, Gatsonis CA. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Statistics in Medicine 2001;20(19):2865-84. [MEDLINE: 11568945]
111. Copyright SAS Institute Inc. SAS. Version 9.2. Cary, NC, USA: Copyright SAS Institute Inc.
112. Schinkel AFL, Bax JJ, Geleijnse ML, Boersma E, Elhendy A, Roelandt JR, et al. Noninvasive evaluation of ischaemic heart disease: myocardial perfusion imaging or stress echocardiography?. European Heart Journal. 2003;24(9):789-800. [MEDLINE: 12727146]
113. Sezer M, Ozcan M, Okcular I, Elitok A. Umman S. Umman B, et al. A potential evidence to explain the reason behind the devastating prognosis of coronary artery disease in uraemic patients: Renal insufficiency is associated with poor coronary collateral vessel development. International journal of cardiology 2007;115(3):366-72. [MEDLINE: 16793151]
114. Smidt N, Deeks J, Moore T (editors). Chapter 4: Guide to the contents of a Cochrane review and protocol. http://srdta.cochrane.org/sites/srdta.cochrane.org/files/uploads/Handbook1CC_Chapter04_101.pdf (accessed 25 May 2010).
115. Wang LW, Fahim MA, Hayen A, Mitchell RL, Baines L, Lord S, et al. Cardiac testing for coronary artery disease in potential kidney transplant recipients: a systematic review of test accuracy studies. American Journal of Kidney Diseases. 2011;57(3):476-87. [DOI: 10.1053/j.ajkd.2010.11.018; MEDLINE: 21257239]
116. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Medical Research Methodology 2003;3:25. [MEDLINE: 14606960]
117. Yao Q, Pecoits-Filho R, Lindholm B, Stenvinkel P. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease. Scandinavian Journal of Urology and Nephrology 2004;38(5):405-16. [MEDLINE: 15764253]